Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kountouras, J., Kapetanakis N., Zavos C., Romiopoulos I., Polyzos S. A., Tsiaousi E., et al. (2013).  Impact of Helicobacter pylori Infection on colon oncogenesis.. Am J Gastroenterol. 108(4), 625-6.
Kountouras, J., Gavalas E., Polyzos S. A., Deretzi G., Kouklakis G., Grigoriadis S., et al. (2014).  Association between Helicobacter pylori burden and Alzheimer's disease.. Eur J Neurol. 21(12), e100.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., Tsiaousi E., et al. (2011).  Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?. Exp Eye Res. 92(5), 436-8.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Polyzos S., Vardaka E., et al. (2011).  Helicobacter pylori may play an important role in both axonal type Guillain-Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy.. Clin Neurol Neurosurg. 113(6), 520.
Kountouras, J., Tsiaousi E., Trigonis S., Polyzos S. A., Katsinelos P., Zavos C., et al. (2016).  Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia".. Eur Rev Med Pharmacol Sci. 20(1), 3-4.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Kountouras, J., Zavos C., Polyzos S. A., Romiopoulos I., Stergiopoulos C., Tsiaousi E., et al. (2013).  Is Helicobacter pylori the usual suspect behind gastroesophageal reflux disease and dacryostenosis?. Med Hypotheses. 81(1), 147.
Kountouras, J., Deretzi G., Zavos C., Gavalas E., Polyzos S. A., Klonizakis P., et al. (2012).  Helicobacter pylori's potential association with epilepsy.. Seizure. 21(2), 151.
Kountouras, J., Kazakos E., Gatopoulou A., Polyzos S. A., Touloumtzi M., Kyrailidi F., et al. (2023).  Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels.. Aliment Pharmacol Ther. 58(11-12), 1252-1253.
Kountouras, J., Polyzos S. A., Gavalas E., Boziki M., Katsinelos P., Zeglinas C., et al. (2016).  A potential impact of Helicobacter pylori infection on minimal hepatic encephalopathy pathobiology.. J Gastrointestin Liver Dis. 25(3), 405-6.
Kountouras, J., Deretzi G., Zavos C., & Katsinelos P. (2014).  A possible impact of common worldwide environmental agents on the prognosis of critically ill cirrhotic patients.. Liver Int. 34(7), 1127-8.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., et al. (2009).  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.. J Neurol. 256(5), 758-67.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
Kountouras, J., Patsiaoura K., Zavos C., Chatzopoulos D., Katsinelos P., Tantsi N., et al. (2014).  Letter: apoptosis and hepatic fibrosis in chronic hepatitis B.. Aliment Pharmacol Ther. 39(9), 996.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2016).  Potential impact of Helicobacter pylori-related human β-defensin-1 on hepatic encephalopathy and neurodegeneration.. Ann Gastroenterol. 29(1), 99.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Kountouras, J., Doulberis M., Polyzos S. A., & Katsinelos P. (2019).  Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease.. Ann Gastroenterol. 32(2), 214.
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 
Kountouras, J., Zavos C., Gavalas E., Deretzi G., Tsona A., Katsinelos P., et al. (2012).  A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.. Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
Kountouras, J., Polyzos S. A., Zavos C., Deretzi G., Kountouras C., Vardaka E., et al. (2014).  Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors.. Hepatology. 60(4), 1450-1.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές